Feed RARE
RA
Ultragenyx Pharmaceutical
RARE · NASDAQ
$27.65 -3.44% (-$0.98)
1M +1.81%
Market Cap $2.7B
P/E Ratio -
Div. Yield -
ROE 411.04%
Bulios Fair Price
$197.67
615.0% upside
Trenutna cena
$27.65
Podcenjeno Poštena vrednost Precenjeno
Valuation
10 /100
Expensive P/S 4.05x
P/B 297.27x
P/E N/A
Growth
100 /100
Growing Rev. growth 22.81%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 83.85%
Net margin 0.00%
Op. margin 0.00%
Quality
0 /100
Poor ROIC 0.00%
ROE 0.00%
ROA 0.00%
Debt
43 /100
Moderate Debt/Equity 94.24x
Current ratio 1.89x
Int. coverage -8.37x
Stability
61 /100
Moderate Beta 0.31x
Rev. volatility 5.31%
EPS volatility 8.40%
Vprašajte StockBota o RARE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Emil D. Kakkis
Employees
1,371
Headquarters
Novato
Prihajajoči dogodki
04 AVG.
Earnings
Upcoming earnings report